PLCO EEMS Seeks Applicants
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial data and biospecimens are available to qualified researchers through a peer-review process. The Etiologic and Early Marker Studies (EEMS) program accepts proposals for access to PLCO biospecimens twice a year, in June/July and December/January.
By collecting biologic materials and risk-factor information from trial participants before the diagnosis of disease, EEMS—a component of the PLCO—provides a resource for cancer researchers who are focused on cancer etiology and early markers. Etiologic studies investigate the environmental, biochemical, and genetic risk factors for cancer. Early detection studies aim to develop reproducible, reliable biomarkers of early disease.
Proposals will be accepted for the EEMS summer review cycle starting June 1, 2010. Applications will be accepted until July 15, 2010, at 5:00 p.m. EDT. Details of the review process and application materials are available at http://www.plcostars.com. Questions may be directed to email@example.com or 240-314-5896.
Enter the Celebrating Smokefree Voices Video Contest
Smokefree Women is launching a video contest, Celebrating Smokefree Voices, to capture the variety of quitting experiences and reasons for quitting smoking among women and their friends and families across the United States. These videos are an opportunity to share reasons why being smokefree is important to you.
There are two categories for video submissions:
- Why I Am a Smokefree Woman: Create a video that tells others why you stay smokefree. What are your reasons and motivations? What does it mean to you to be a smokefree woman?
- Why I Want YOU to be Smokefree: Is there a woman in your life that you care about who smokes? Create a video and let them know why you want them to enjoy a smokefree life and the freedom from cigarettes.
Three winners named in each category will receive prizes of up to $2,000.
All video entries must be submitted by June 4, along with the required video entry form. Contest winners will be announced on July 2, right before Independence Day, to celebrate independence from smoking.
Visit http://women.smokefree.gov to watch the call-for-submissions video and to find contest instructions.
Meet NCI Experts at ASCO
Learn about NCI’s programs and Web sites by visiting booth #2033 in the exhibit hall during the 2010 American Society of Clinical Oncology annual meeting. NCI experts will be available to talk about a wide range of topics. See the schedule below.
Saturday, June 5
Ellen Richmond and Linda Parreco
|12:00 p.m.||Funding for Biomarker, Imaging, & QOL Studies Associated with NCI’s Clinical Trials|
|1:00 p.m.||NCI Online Course: Including Clinical Trials in Your Practice|
Rose Mary Padberg
|2:00 p.m.||Using TNF-alpha Antagonists to Treat Primary Tumors and Tumor Metastases|
Holly Massett and Rose Mary Padberg
|4:00 p.m.||Cancer Training Branch|
Sunday, June 6
|10:00 a.m.||NCI Online Course: Including Clinical Trials in Your Practice|
|11:00 a.m.||NCI’s Office of Cancer Complementary and Alternative Medicine|
|12:00 p.m.||Overview of Specialized Programs of Research Excellence (SPOREs)|
|1:00 p.m.||NCI SBIR Funding for Small Startup Businesses to Bring Science to the Market|
|2:00 p.m.||Using TNF-alpha Antagonists to Treat Primary Tumor and Tumor Metastases|
|3:00 p.m.||Funding for Biomarker, Imaging, & QOL Studies Associated with NCI’s Clinical Trials|
|4:00 p.m.||Funding Opportunities to Promote Workplace Diversity|
John O. Ojeifo
Monday, June 7
|9:00 a.m.||Translational Research Program (SPOREs)|
|11:00 a.m.||Funding for Biomarker, Imaging, & QOL Studies Associated with NCI’s Clinical Trials|
Abstracts Accepted for the Molecular Markers in Cancer Meeting
The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer will be held October 18–20 in Hollywood, FL. Participants will discuss the rapidly advancing field of cancer markers and practical applications for biomarker research and treatment. Abstract submissions on the following topics are being accepted through June 22:
- Clinical applications of biomarkers
- Application of new and established technologies and platforms
- Immune system and immunotherapeutic markers
- DNA repair and apoptosis
- Circulating tumor cells and cancer stem cells
- Cell signaling pathways
- Genetics, genomics, epigenetics, gene expression
President’s Cancer Panel Issues Report on Environmental Cancer Risks
On May 6, the President’s Cancer Panel issued a report titled “Reducing Environmental Cancer Risk: What We Can Do Now.” The report summarizes the Panel’s findings from four meetings convened between September 2008 and January 2009 to assess the state of environmental cancer research, policy, and programs addressing known and potential effects of environmental exposures on cancer. The report’s conclusions are based on the information gathered at those four meetings, as well as testimony received from 45 invited experts from academia, government, industry, environmental and cancer advocacy communities, and the public. The Panel’s recommendations delineate specific actions that governments; industry; the research, health care, and advocacy communities; and individuals can take to reduce cancer risk related to environmental contaminants, excess radiation, and other harmful exposures.
This latest report from the Panel is one of a series. Two previous reports addressed promoting healthy lifestyles and maximizing the nation’s investment in cancer research.
Updated NCI Spanish-language Booklet on Breast Cancer
NCI has released a newly revised Spanish-language booklet for recently diagnosed breast cancer patients titled Lo que usted necesita saber sobre el cancer de seno (What You Need To Know About Breast Cancer). This booklet tells about diagnosis, treatment choices by stage, breast reconstruction, and follow-up care. It also describes how to take part in research studies and includes lists of questions to ask a physician.
This booklet and the other eight Spanish booklets in the series are available at Cancer.gov en español. Order copies of these and other NCI education materials from the NCI Publications Locator Web site or by calling 1-800-4-CANCER.